Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 24.20M $375.10M Dec. 31, 2014
PRIMECAP Management Company 18.23M $282.50M Dec. 31, 2014
HealthCor Management 9.20M $66.88M June 30, 2011
Vanguard 8.30M $128.72M Dec. 31, 2014
Ulys 5.17M $28.93M Dec. 31, 2011
First Trust Advisors 5.01M $77.71M Dec. 31, 2014
Federated Investors 4.99M $77.27M Dec. 31, 2014
JPMORGAN CHASE & CO 4.86M $75.36M Dec. 31, 2014
BlackRock Fund Advisors 4.73M $73.37M Dec. 31, 2014
Inves 4.13M $64.09M Dec. 31, 2014
STATE STREET CORPORATION 4.12M $63.84M Dec. 31, 2014
HealthCor Management 4.00M $46.20M June 30, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.51M $54.40M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 3.40M $52.77M Dec. 31, 2014
Franklin Resources 3.04M $38.93M June 30, 2014
Deerfield Management Company 2.94M $33.95M June 30, 2013
Invus Public Equities Advisors 2.75M $19.99M June 30, 2011
BVF 2.73M $20.26M Dec. 31, 2012
Barclays 2.71M $21.48M March 31, 2012
Artal Group S.A. 2.50M $28.88M June 30, 2013

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M
Tudor Investment Corporation June 30, 2004 2.49M $49.79M